• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

tetano

Editor, Senior Moderator
Cell


. 2020 Aug 5;S0092-8674(20)30992-2.
doi: 10.1016/j.cell.2020.08.001. Online ahead of print.
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment


Jonas Schulte-Schrepping[SUP] 1 [/SUP], Nico Reusch[SUP] 1 [/SUP], Daniela Paclik[SUP] 2 [/SUP], Kevin Ba?ler[SUP] 1 [/SUP], Stephan Schlickeiser[SUP] 3 [/SUP], Bowen Zhang[SUP] 4 [/SUP], Benjamin Kr?mer[SUP] 5 [/SUP], Tobias Krammer[SUP] 6 [/SUP], Sophia Brumhard[SUP] 7 [/SUP], Lorenzo Bonaguro[SUP] 1 [/SUP], Elena De Domenico[SUP] 8 [/SUP], Daniel Wendisch[SUP] 7 [/SUP], Martin Grasshoff[SUP] 4 [/SUP], Theodore S Kapellos[SUP] 1 [/SUP], Michael Beckstette[SUP] 4 [/SUP], Tal Pecht[SUP] 1 [/SUP], Adem Saglam[SUP] 8 [/SUP], Oliver Dietrich[SUP] 6 [/SUP], Henrik E Mei[SUP] 9 [/SUP], Axel R Schulz[SUP] 9 [/SUP], Claudia Conrad[SUP] 7 [/SUP], D?sir?e Kunkel[SUP] 10 [/SUP], Ehsan Vafadarnejad[SUP] 6 [/SUP], Cheng-Jian Xu[SUP] 11 [/SUP], Arik Horne[SUP] 1 [/SUP], Miriam Herbert[SUP] 1 [/SUP], Anna Drews[SUP] 8 [/SUP], Charlotte Thibeault[SUP] 7 [/SUP], Moritz Pfeiffer[SUP] 7 [/SUP], Stefan Hippenstiel[SUP] 12 [/SUP], Andreas Hocke[SUP] 12 [/SUP], Holger M?ller-Redetzky[SUP] 7 [/SUP], Katrin-Moira Heim[SUP] 7 [/SUP], Felix Machleidt[SUP] 7 [/SUP], Alexander Uhrig[SUP] 7 [/SUP], Laure Bosquillon de Jarcy[SUP] 7 [/SUP], Linda J?rgens[SUP] 7 [/SUP], Miriam Stegemann[SUP] 7 [/SUP], Christoph R Gl?senkamp[SUP] 7 [/SUP], Hans-Dieter Volk[SUP] 13 [/SUP], Christine Goffinet[SUP] 14 [/SUP], Markus Landthaler[SUP] 15 [/SUP], Emanuel Wyler[SUP] 15 [/SUP], Philipp Georg[SUP] 7 [/SUP], Maria Schneider[SUP] 2 [/SUP], Chantip Dang-Heine[SUP] 16 [/SUP], Nick Neuwinger[SUP] 17 [/SUP], Kai Kappert[SUP] 17 [/SUP], Rudolf Tauber[SUP] 17 [/SUP], Victor Corman[SUP] 18 [/SUP], Jan Raabe[SUP] 5 [/SUP], Kim Melanie Kaiser[SUP] 5 [/SUP], Michael To Vinh[SUP] 5 [/SUP], Gereon Rieke[SUP] 5 [/SUP], Christian Meisel[SUP] 19 [/SUP], Thomas Ulas[SUP] 8 [/SUP], Matthias Becker[SUP] 8 [/SUP], Robert Geffers[SUP] 20 [/SUP], Martin Witzenrath[SUP] 12 [/SUP], Christian Drosten[SUP] 21 [/SUP], Norbert Suttorp[SUP] 12 [/SUP], Christof von Kalle[SUP] 16 [/SUP], Florian Kurth[SUP] 22 [/SUP], Kristian H?ndler[SUP] 8 [/SUP], Joachim L Schultze[SUP] 23 [/SUP], Anna C Aschenbrenner[SUP] 24 [/SUP], Yang Li[SUP] 11 [/SUP], Jacob Nattermann[SUP] 25 [/SUP], Birgit Sawitzki[SUP] 2 [/SUP], Antoine-Emmanuel Saliba[SUP] 6 [/SUP], Leif Erik Sander[SUP] 12 [/SUP], Deutsche COVID-19 OMICS Initiative (DeCOI)



Collaborators, Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tract infection, however, a subset of patients progress to severe disease and respiratory failure. The mechanism of protective immunity in mild forms and the pathogenesis of severe COVID-19 associated with increased neutrophil counts and dysregulated immune responses remain unclear. In a dual-center, two-cohort study, we combined single-cell RNA-sequencing and single-cell proteomics of whole-blood and peripheral-blood mononuclear cells to determine changes in immune cell composition and activation in mild versus severe COVID-19 (242 samples from 109 individuals) over time. HLA-DR[SUP]hi[/SUP]CD11c[SUP]hi[/SUP] inflammatory monocytes with an interferon-stimulated gene signature were elevated in mild COVID-19. Severe COVID-19 was marked by occurrence of neutrophil precursors, as evidence of emergency myelopoiesis, dysfunctional mature neutrophils, and HLA-DR[SUP]lo[/SUP] monocytes. Our study provides detailed insights into the systemic immune response to SARS-CoV-2 infection and reveals profound alterations in the myeloid cell compartment associated with severe COVID-19.

Keywords: COVID-19; SARS-CoV-2; dysfunctional neutrophils; emergency myelopoiesis; immune profiling; mass cytometry; monocytes; neutrophils; scRNA-seq.
 
Back
Top Bottom